May 01, 2018

Persistence Pays Off in Discovery That Could Lead to Improved Treatment and Survivability of Patients with Brain Tumors

Gliomas are the most common type of central nervous system cancer but how these tumors develop is not fully understood. Sheri Holmen, PhD a researcher at Huntsman Cancer Institute and professor of surgery at the University of Utah just published the results of her research on gliomas in Cell Reports. The work is focused on a mutated gene that is a critical piece of the puzzle for glioma development, according to Holmen’s work.

Apr 27, 2018

Huntsman Cancer Institute Researchers Attend and Share Expertise at National Cancer Meeting

“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research annual meeting, which took place April 14-18 in Chicago. Huntsman Cancer Institute faculty and staff joined almost 22,000 other scientists, physicians, and patient advocates from around the world to share the latest findings in translational, clinical, and prevention-focused cancer research.

Mar 15, 2018

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

Huntsman Cancer Institute at the University of Utah has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society. The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.

Mar 13, 2018

Surprising Discovery Provides Insights into Aggressive Endometrial Cancers

New research from Huntsman Cancer Institute at the University of Utah indicates steroid and hormone receptors are simultaneously active in many endometrial cancer tissues. The findings, published today in the journal Cell Reports, yield insights about factors that contribute to more aggressive endometrial tumors.

Mar 08, 2018

Talks with Docs: Theresa Werner, MD

Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She talks with us about the optimistic women she treats in clinic and a stylish first lady of the United States she would trade lives with for a day.

Feb 27, 2018

New understanding of enzyme’s role in development of certain brain and spinal cord tumors

In a study recently published in Acta Neuropathologica, L. Eric Huang, MD, PhD, Huntsman Cancer Institute researcher and associate professor of neurosurgery at the University of Utah, and colleagues report on new findings in the function of an enzyme, IDH1, in the development of gliomas. Gliomas are life-threatening tumors of brain or spinal cord tissue, and this type of tumor affects approximately 25,000 people each year. As changes in IDH1 are found in the vast majority of gliomas, understanding the impact of IDH1 enzyme function is critical to advancing research in this disease.

Feb 15, 2018

Navigating Cancer at a Young Age

For many of young people, a cancer diagnosis is their first real medical issue. This was the case for Marina Pimentel, who was diagnosed with Hodgkin lymphoma, a type of blood cancer, at age 26. Marina worked with an AYA patient navigator to help her manage the complexities of cancer treatment and care.

Feb 15, 2018

Total Cancer Care: Coming Together to Find Cures

Christina Ratcliff enrolled in HCI's Total Cancer Care study, a partnership among patients, health care providers, and researchers to help accelerate cancer research and improve patient care.